Diverticulitis Clinical Trial
— IMPEDEOfficial title:
Investigation of Medical Management to Prevent Episodes of Diverticulitis (IMPEDE) Trial
This is a randomized trial (n=75) of a Mediterranean style Food Pattern and versus standardized guidance on fiber intake for patients with diverticulitis to evaluate the feasibility of this dietary intervention including willingness to randomize and adherence to a Med-style dietary pattern. The investigators will employ state-of-the-art behavioral interventions in the form of electronic feedback to improve health-related behaviors and support dietary customization based on participants' budget, dietary preferences, and restrictions. The investigators will also examine plasma inflammatory biomarkers (interleukin-6, interleukin-10, and interleukin-1β) and fecal calprotectin at baseline, 6, and 12 months.
Status | Recruiting |
Enrollment | 75 |
Est. completion date | April 1, 2025 |
Est. primary completion date | April 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult =18 years; - Patients presenting (or recently presented) to gastroenterologist or surgeons or accessing study website after recovery from an episode of diverticulitis (within the prior 18 months), either the index episode or recurrent. - Ability to provide written informed consent in English. Exclusion Criteria: - Unable or unwilling to return for specimen collection visits or be contacted for and/or complete research surveys; - Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening; - Last episode of acute diverticulitis currently unresolved (i.e., on antibiotics for diverticulitis; drain in place); - Intolerance/allergy to the main components of the Med-style food pattern; - Surgery for diverticulitis within past 6 months without an episode of diverticulitis post-surgery; - Planned elective surgery in next 6 months |
Country | Name | City | State |
---|---|---|---|
United States | Harborview Medical Center | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
University of Washington | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Willingness to enroll | Number of randomized participants out of number approached | through study completion, over a period of 2 years | |
Primary | Adherence to Med-Style Food Pattern | Med-style Pattern score calculated from the Nutrition Assessment Shared Resource Food Frequency Questionnaire | through study completion, over a period of 12 months | |
Primary | Participant retention | Proportion enrolled and retained at 3, 6, 9 and 12 months | through study completion, over a period of 12 months | |
Primary | Engagement with nutrition services | Number of sessions with dietician | Quarterly through study completion, over a period of 12 months | |
Primary | Interaction with online program | Number of times accessed | Bi-weekly through study completion, over a period of 12 months | |
Secondary | Change in Plasma, Interleukin (IL)-6, IL-10, IL-1b, fecal calprotectin | Concentration | Baseline, 6, 12 months through study completion, over a period of 12 months | |
Secondary | Diverticulitis events | Self-reported (presumed), subset of those resulting in healthcare utilization (e.g., hospitalization, surgery). | Quarterly through study completion, over a period of 12 months | |
Secondary | National Surgical Quality Improvement Program (NSQIP)-defined complications, a subset of which are serious adverse events to be reported to Independent Safety Monitor | Standardized assessment-serious events defined as death, cardiac arrest, myocardial infarction, pneumonia, progressive renal insufficiency, acute renal failure, pulmonary embolism, deep vein thrombosis, return to operating room, serious site infections | Quarterly through study completion, over a period of 12 months | |
Secondary | Change in Diverticulitis Quality of Life Survey (DVQOL) | A 17-item questionnaire that assesses four domains: symptoms, concerns, emotions, and behavior changes related to diverticulitis, ranging from 0 (best) to 10 (worst) | Baseline, 6, 12 months | |
Secondary | Change in Gastrointestinal Quality of Life Index (GIQLI) | A 36-item questionnaire that assesses five domains: gastrointestinal symptoms, physical function, emotional well-being, social well-being, and perception of medical treatment measured by a single item question. Each item has 5 response choices (i.e., all of the time, most of the time, some of the time, a little of the time, never). In addition, the measure produces an overall QoL score (0-144) where higher numbers indicate greater QoL. | Baseline, 6, 12 months | |
Secondary | Change in International Physical Activity Questionnaire (IPAQ) short form | A validated 7-item questionnaire: moderate and vigorous physical activity, walking, and sitting in the past 7 days. Output is self-reported minutes of moderate and vigorous physical activity as well as walking from which weekly moderate and vigorous physical activity, sitting, and walking can be assessed. | Baseline, 6, 12 months | |
Secondary | Healthcare utilization | Counts of ED/hospital encounters, diverticulitis-related diagnostic/therapeutic interventions | Quarterly through study completion, at 3, 6, 9, 12 months | |
Secondary | Change in self-reported weight | Self-reported weight | Baseline, 6, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT02246361 -
Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
|
Phase 4 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01081054 -
Hospitalization or Ambulatory Treatment of Acute Diverticulitis
|
Phase 4 | |
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Completed |
NCT03337984 -
Damage Control Surgery in the Treatment of Complicated Diverticulitis
|
||
Recruiting |
NCT06210724 -
FIT in Diverticulitis
|
||
Completed |
NCT01986686 -
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
|
N/A | |
Completed |
NCT01477190 -
Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program
|
Phase 1/Phase 2 | |
Completed |
NCT01056913 -
NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
|
Phase 4 | |
Completed |
NCT00468455 -
Post-Op Quality of Life After Colorectal Surgery
|
N/A | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Enrolling by invitation |
NCT03700593 -
Feasibility and Safety of Single Port Robot in Colorectal Procedures
|
||
Recruiting |
NCT04095663 -
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
|
N/A | |
Completed |
NCT00545740 -
Prevention of Recurrence of Diverticulitis
|
Phase 3 | |
Recruiting |
NCT01837342 -
Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery
|
N/A | |
Completed |
NCT01727388 -
Informativeness to Digital Rectal Examination
|
Phase 3 | |
Completed |
NCT00554099 -
Asacol Acute Diverticulitis(DIVA)Study
|
Phase 2 | |
Completed |
NCT04173182 -
Confocal Laser Endomicrospy in Colonic Diverticular Disease
|
||
Completed |
NCT01560377 -
Perfusion Assessment in Laparoscopic Left Anterior Resection
|
Phase 1 |